Axil Capital is a venture capital firm based in Tokyo, Japan, specializing in biomedical & healthcare technology investments, with emphasis on supporting the growth of early stage ventures.  

What's New

October 6, 2020

Our portfolio company, C4 Therapeutics Inc. (CCCC), successfully completed its IPO listing on the NASDAQ exchange

October 3, 2019

Our portfolio company, Frequency Therapeutics Inc. (FREQ), successfully completed its IPO listing on the NASDAQ exchange